Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mifepristone for ectopic ACTH Cushing's syndrome
2006-004679-36Phase 2Terminated
- Sponsor
- HRA Pharma
- Start
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of mifepristone in Cushing's syndrome and ectopic corticotropin syndrome (ECS), sponsored by HRA Pharma. Started Sep 2006; status: terminated.
02
Drugs
mifepristone
03
Conditions
Cushing's syndromeectopic corticotropin syndrome (ECS)
Beyond the preview
Go deeper on 2006-004679-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004679-36.